Letter Agreement Granting Participation Rights in Future Equity Financing between DOR BioPharma, Inc. and Iroquois Master Fund, Ltd. (September 23, 2009)
Contract Categories:
Business Finance
›
Equity Distribution Agreements
Summary
DOR BioPharma, Inc. and Iroquois Master Fund, Ltd. entered into an agreement granting Iroquois the right to invest up to $750,000 in DOR BioPharma’s next equity financing within 12 months, as consideration for Iroquois’ current $750,000 investment. To exercise this right, Iroquois must commit in writing within 10 days of receiving notice of the new financing. This agreement outlines the terms for Iroquois’ participation in future equity offerings by DOR BioPharma.
EX-10.33 5 fs1ex10xxxiii_soligenix.htm LETTER AGREEMENT DATED SEPTEMBER 23, 2009 BETWEEN THE COMPANY AND IROQUOIS MASTER FUND, LP, LLC fs1ex10xxxiii_soligenix.htm
EXHIBIT 10.33
[DOR BIOPHARMA, INC. LETTERHEAD]
September 23, 2009
Joshua Silverman
Managing Member
Iroquois Capital Management, LLC
641 Lexington Avenue, 26th Floor
New York, NY 10022
Dear Mr. Silverman:
In consideration for Iroquois’ investment of $750,000 in our equity financing that is closing on this date, we hereby offer Iroquois the right to participate in an amount up to $750,000 in our next equity financing within 12 months from the date of this letter. In order for Iroquois to have the right to purchase the securities offered in such financing, Iroquois must unconditionally commit in writing to participate in accordance with the terms of the financing within 10 days after we provide written notice thereof to you.
If you are in agreement with this letter, please sign this letter in the space provided below.
Very truly yours,
/s/ Christopher J. Schaber
Christopher J. Schaber, PhD
Chief Executive Officer
AGREED AND ACCEPTED
Iroquois Master Fund, Ltd.
By: /s/ Joshua Silverman
Joshua Silverman
